Estimation of Additional Costs in Patients with Ventilator-Associated Pneumonia
Antibiotics · 19.12.2023 · 13 (1) · 2
DOI: 10.3390/antibiotics13010002 ↗Kurz gefasst
Fachartikel in der Zeitschrift Antibiotics, online erschienen am 19.12.2023. Verfasst von Ginger G Cabrera-Tejada und 8 weiteren Autor:innen. Beteiligte Einrichtung: Preventive Medicine Service, Dr. Balmis General University Hospital, 03010 Alicante, Spain. Die Arbeit wurde bisher 31-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Alicante Institute for Health and Biomedical Research (ISABIAL).
Themen: Pneumonieprophylaxe
Abstract (Originalsprache)
Healthcare-associated infections (HAIs) present a global public health challenge, contributing to high morbidity and mortality and substantial economic burdens. Ventilator-associated pneumonia (VAP) ranks as the second most prevalent HAI in intensive care units (ICUs), emphasizing the need for economic analyses in this context. This retrospective cohort study, conducted at the General Hospital of Alicante from 2012 to 2019, aimed to assess additional costs related to VAP by comparing the extended length of stay for infected and non-infected ICU patients undergoing mechanical ventilation (MV) for more than 48 h. Employing propensity score association, 434 VAP patients were compared to an equal number without VAP. The findings indicate a significantly longer mechanical ventilation period for VAP patients (17.40 vs. 8.93 days, p < 0.001), resulting in an extra 13.56 days of stay and an additional cost of EUR 20,965.28 per VAP episode. The study estimated a total cost of EUR 12,348,965.28 for VAP during the study period, underscoring the economic impact of VAP. These findings underscore the urgent need for rigorous infection surveillance, prevention, and control measures to enhance healthcare quality and reduce overall expenditures.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Preventive Medicine Service, Dr. Balmis General University Hospital, 03010 Alicante, Spain.
- Epidemiology Unit, Preventive Medicine Service, Dr. Balmis General University Hospital, Alicante Institute for Health and Biomedical Research (ISABIAL), 03010 Alicante, Spain.
- Medical Intensive Care Unit, Dr. Balmis General University Hospital, Alicante Institute for Health and Biomedical Research (ISABIAL), 03010 Alicante, Spain.
- Anesthesiology Service and Surgical Intensive Care Unit, Dr. Balmis General University Hospital, Alicante Institute for Health and Biomedical Research (ISABIAL), 03010 Alicante, Spain.
- Public Health Research Group, University of Alicante, San Vicente de Raspeig, 03690 Alicante, Spain.
- Biomedical Research Networking Center (CIBERESP), 28029 Madrid, Spain.
ORCID-Profile: Pablo Chico-Sánchez, Maria Galiana-Ivars, Isel L Gómez-Sotero, Elena Ronda-Pérez
Förderung
- Alicante Institute for Health and Biomedical Research (ISABIAL)
Zitieren
APA
Cabrera-Tejada, G. G., Chico-Sánchez, P., Gras-Valentí, P., Jaime-Sánchez, F. A., Galiana-Ivars, M., Balboa-Esteve, S., Gómez-Sotero, I. L., Sánchez-Payá, J., & Ronda-Pérez, E. (2023). Estimation of Additional Costs in Patients with Ventilator-Associated Pneumonia. Antibiotics, 13(1), 2. https://doi.org/10.3390/antibiotics13010002
Vancouver
Cabrera-Tejada GG, Chico-Sánchez P, Gras-Valentí P, Jaime-Sánchez FA, Galiana-Ivars M, Balboa-Esteve S, et al. Estimation of Additional Costs in Patients with Ventilator-Associated Pneumonia. Antibiotics. 2023;13(1):2. doi:10.3390/antibiotics13010002
BibTeX
@article{CabreraTejada2023,
author = {Cabrera-Tejada, Ginger G and Chico-Sánchez, Pablo and Gras-Valentí, Paula and Jaime-Sánchez, Francisco A and Galiana-Ivars, Maria and Balboa-Esteve, Sonia and Gómez-Sotero, Isel L and Sánchez-Payá, José and Ronda-Pérez, Elena},
title = {Estimation of Additional Costs in Patients with Ventilator-Associated Pneumonia},
journal = {Antibiotics},
year = {2023},
volume = {13},
number = {1},
pages = {2},
doi = {10.3390/antibiotics13010002}
}
EUVIMED